JESSICA TULLIS: Open Payments
NPI 1568951887 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 79 payments from 25 companies in 2025. Trend: 2023 $1,503 · 2024 $1,711 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $416 |
| ABBVIE INC. | 14 | $272 |
| Lilly USA, LLC | 6 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $153 |
| Novo Nordisk Inc | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: NURTEC ODT, MOUNJARO, CAPLYTA, QULIPTA, ZAVZPRET, UBRELVY, REXULTI, Wegovy.
Industry payments across IN — which companies pay providers there.
